Skip to main content
Premium Trial:

Request an Annual Quote

Berg: 'Don't Be Shy' About Defending Fundamental Model Organism Research

During his keynote address at the Genetics Society of America: Model Organisms to Human Biology meeting in Boston this week, National Institute of General Medical Sciences director Jeremy Berg spoke about advances in pharmacogenomics related to warfarin dosing, the recent NIH-wide changes to grant applications, and NIGMS genetics and genomics resources for those who study model organisms, "from A to Z — from Arabidopsis to zebrafish." Berg also spoke about how investigators who use model organisms in their work might be most likely to receive NIGMS funding for their work. Namely, Berg said that the most important factors in an NIGMS grant application are "significance, approach, and innovation," with the greatest emphasis on "How important is something if it works? How likely is it to work, and how likely is it that there'll be something else discovered along the way that could turn out to be important?" The NIGMS director told meeting attendees that many model organism researchers make the mistake is "trying to oversell potential translational applications, rather than saying 'gene regulation is really important for all biology and we really need to understand it as much as we possibly can.'" Many model organism research proposals which read "some genes are disregulated in cancer and therefore we're going to …" put the applicant at risk later on, he said, when it seems they're "being forced to deliver the goods about how you're going to get this into the clinic" — a conversation that "doesn't always go well." Berg told attendees that, on occasion, researchers will be required to defend their use of model organisms to study section members. "If you're going to use a model organism, say why," Berg said. "Don't be shy about defending … why it's better than the alternatives." Overall, he said, geneticists and genomicists studying nematodes, flies, mice, and other organisms, shouldn't "be shy about saying 'this research is significant because it's fundamental biology that's really important to human health and disease.'"

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.